3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
85
Stomach Neoplasms
16
Esophageal Neoplasms
14
Neoplasms
10
Cholangiocarcinoma
10
Carcinoma, Non-Small-Cell Lung
10
Breast Neoplasms
9
Neoplasm Metastasis
8
Adenocarcinoma Of Esophagus
8
Esophageal Squamous Cell Carcinoma
7
Endometrial Neoplasms
7
Colorectal Neoplasms
7
Pancreatic Adenocarcinoma
6
Ovarian Neoplasms
6
Lung Neoplasms
6
Gallbladder Neoplasms
6
Carcinoma, Ovarian Epithelial
6
Adenocarcinoma
5
Squamous Cell Carcinoma of Head and Neck
4
Prostatic Neoplasms
4
Melanoma
4
Biliary Tract Neoplasms
4
Urinary Bladder Neoplasms
3
Sarcoma
3
Liver Neoplasms
3
Gastric Adenocarcinoma
3
Colonic Neoplasms
3
Carcinoma, Renal Cell
3
Anus Neoplasms
3
Advanced Pancreatic Cancer
3
Interventions
Gemcitabine
4
130-nm albumin-bound paclitaxel
3
Pancreaticoduodenectomy
2
Oxaliplatin
2
Irinotecan
2
titanium silicide
1
tislelizumab
1
sonidegib
1
paricalcitol
1
mitazalimab
1
lenvatinib
1
ivosidenib
1
irinotecan sucrosofate
1
glucoraphanin
1
devimistat
1
Transurethral Resection of Prostate
1
Tissue Banks
1
Taxes
1
Specimen Handling
1
Saline Solution
1
S 1 (combination)
1
Ropivacaine
1
Robotic Surgical Procedures
1
Radiomics
1
Positron Emission Tomography Computed Tomography
1
Parturition
1
PEGPH20
1
Neoadjuvant Therapy
1
Magnetic Resonance Spectroscopy
1
Losartan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Pancreatic Ductal Adenocarcinoma
×
Taxes
×
Gastrointestinal
×
Clear all
NCT04827953
2024-12-30
NUMANTIA
Nelum Corp
Phase 1/2
Active not recruiting
28 enrolled